DC EKG

Joe Grogan

julie@julieriga.com

For verified host and producer emails, sign up to view.

Booking Overview

DC EKG is a policy-focused healthcare podcast hosted by former White House policy expert Joe Grogan, using interviews to translate complex healthcare legislation into real-world patient and provider impacts. Guests are typically health-policy and economics authorities—often with direct Capitol Hill, federal, or research credentials—making it a strong platform for thought leadership on Medicare, drug pricing, and healthcare reform.

Metrics

Episodes: 140

Frequency: Irregular

Rating: 5.0/5.0

Estimated listeners: 1k-10k

Gender skew: Male

Location: USA

Contact Information

julie@julieriga.com

For verified host and producer emails, sign up to view.

Host

Joe Grogan - Former White House policy expert who demystifies the policies shaping the U.S. healthcare system and explains their real-world implications for patients, providers, and payers.

Booking Intelligence

Booking Requirements

medium
Typical Credentials:  
Academic health-policy or health-economics researchers; senior fellows at prominent think tanks; health-policy economists; policy experts with Capitol Hill roles (e.g., Congressional committees/advisory work) or federal-policy relevance.
Required Achievements:  
Published peer-reviewed research or influential policy research, Authorship/co-authorship of major reports or frameworks (e.g., policy declarations or prominent research papers), Leadership roles at universities, think tanks, or major public-policy institutions, Direct experience advising Congress or serving in high-level policy roles

Recent Guest Discussions

Dr. Ike Brannon - Tax Expenditures, 340b Drug Pricing, Kidney Donation Reform And Reimbursement, Medicare/medicaid-style Entitlement Implications (as Framed In The Episode).

Ben Ippolito - Economics Of Glp-1 Weight Loss Drugs, Insurance Coverage Decisions, Medicare Coverage Ban, Gross-to-net Pricing, Inflation Reduction Act Negotiation Impacts, Medicare Advantage Scrutiny.

Dr. Jay Bhattacharya - Covid-19 Seroprevalence, Natural Immunity, Great Barrington Declaration, Scientific Integrity And Policy Suppression Claims.

Recent Topics

Healthcare, Health Policy, Drug Pricing, Medicare, Medicaid

Episodes

Here's the recent few episodes on
DC EKG
:

"REFILL" | Dr. Jay Bhattacharya on COVID Infection Rates, Natural Immunity, and the Great Barrington Declaration (Originally Aired: July 20, 2023)

June 22, 2026

Dr. Jay Bhattacharya on COVID-19 Seroprevalence, Natural Immunity, and the Great Barrington Declaration (Originally Aired July 20, 2023)This episode originally aired on July 20, 2023, the same day Stanford University President Tessier-Levine was forced to resign. Dr. Jay offers detailed commentary on the hostile work environment at Stanford and how government, big tech, and academia conspired to suppress scientific voices.Episode DescriptionIn this wide-ranging conversation, Joe Grogan and Er...

Tax Expenditures, 340 B Drug Pricing, and Kidney Donation Reform

June 15, 2026

DC EKG with Joe Grogan Episode 137: Tax Expenditures, 340 B Drug Pricing, and Kidney Donation Reform Air Date: June 15, 2026 Episode DescriptionIn this episode, Joe Grogan sits down with Dr. Ike Brannon, President of Capital Policy Analytics and Senior Fellow at the Jack Kemp Foundation, to discuss hidden tax expenditures, the 340 B drug pricing program, and innovative solutions to the kidney shortage crisis. Dr. Brannon brings decades of Capitol Hill experience, including...

"REFILL" - The Economics of Ozempic and Other Weight Loss Drugs (Originally Aired: May 2024)

June 08, 2026

DC EKG with Joe GroganThe Economics of Ozempic and Other Weight Loss DrugsEpisode 136.5 (“Prescription Refill” – A replay from the archives)Original Air Date: May 2024In this episode, Joe Grogan welcomes Ben Ippolito, Senior Fellow in Economic Policy Studies at the American Enterprise Institute, to discuss the rapidly evolving economics of GLP-1 weight loss drugs like Ozempic and Wegovy.Ben explains the two main competitors in this market—Novo Nordisk's Ozempic and Wegovy versus Eli Lilly's M...

Get your clients booked on top podcasts

Try us risk free with a FREE 3 days trial.

Start Your Free Trial

Join hundreds of PR teams using Podseeker to pitch and land bookings